These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 756103)

  • 21. [Incidence of anti-delta antibodies in chronic HBsAg carriers].
    Stránský J; Zichová M; Vodák M
    Cas Lek Cesk; 1987 Dec; 126(51):1600-3. PubMed ID: 3442788
    [No Abstract]   [Full Text] [Related]  

  • 22. [Family study on the possible relationship between chronic HBsAg carriers and HLA system haplotypes].
    Montoro JA; Soler MA; Carrasco D; Pérez Castellanos MT; Carbonell F; Ruiz I; Berenguer J; Marty ML
    Sangre (Barc); 1983; 28(2):158-63. PubMed ID: 6879397
    [No Abstract]   [Full Text] [Related]  

  • 23. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of transmission of hepatitis B to hospital personnel exposed to a chronic HBsAg carrier.
    Quraishi ZA; Adler LM; Blais FX
    J Am Osteopath Assoc; 1985 Sep; 85(9):576-9. PubMed ID: 4055445
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prognostic significance of quantitative HBsAg determination in acute hepatitis B. Partial report of a cooperative clinical study of the DFG-focus of "virus hepatitis"].
    Gerlich W; Stamm B; Thomssen R
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():554-7. PubMed ID: 612029
    [No Abstract]   [Full Text] [Related]  

  • 26. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic aspects of asymptomatic chronic carriers of HBsAg].
    Fink de Cabutti NE; Morales VH; Jmlenitzky C; Basualdo Farjat JA; De Torres R
    Sangre (Barc); 1984; 29(4-A):370-5. PubMed ID: 6505927
    [No Abstract]   [Full Text] [Related]  

  • 28. [Subtypes of HBs antigen in Poland].
    Gloskowska-Moraczewska Z; Holland PV; Madaliński K; Kalinowska B
    Acta Haematol Pol; 1976; 7(3):189-93. PubMed ID: 983666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcome of acute viral hepatitis B].
    Tul'chenetskaia TA; Zmyzgova AV
    Sov Med; 1984; (11):100-2. PubMed ID: 6523200
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B surface antigen (HbsAg): (a survey of hospital staff in Zambia).
    Bhagwat GP; Parmar S
    Med J Zambia; 1983 Oct; 17(4):106-8. PubMed ID: 6680555
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B surface antigenemia and HLA antigens.
    Giani G; Chiaramonte M; Pasini CV; Fagiolo U; Naccarato R
    N Engl J Med; 1979 May; 300(18):1056. PubMed ID: 431606
    [No Abstract]   [Full Text] [Related]  

  • 32. HBsAg/IgM complexes in serum of HBsAg carriers: partial characterization and clinical significance.
    Rizzi R; Almi P; Touscoz G; Canese MG; Toti M; Palla M; Bonino F
    Boll Ist Sieroter Milan; 1983 May; 62(2):137-44. PubMed ID: 6626320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is modulation of HLA display by interferon important in preventing the development of the chronic carrier state of hepatitis B virus in adults?
    Thomas HC; Pignatelli M
    Gastroenterol Clin Biol; 1985 Apr; 9(4):287-9. PubMed ID: 2581841
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior and clinical significance of the eAg/ anti-e system in carriers of HBsAg].
    Pastore G; Dentico P; Fera G; Angarano G; Schiraldi O
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):333-8. PubMed ID: 911461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term observation of HBsAg positive patients and carriers (author's transl)].
    Wu BP
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jul; 15(4):245-7. PubMed ID: 7333195
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of HBsAg in the development of chronic liver disease after acute liver hepatitis.
    Miron C; Stoica G; Tănăsescu C; Lăzărescu V; Căruntu V
    Med Interne; 1978; 16(4):369-74. PubMed ID: 749174
    [No Abstract]   [Full Text] [Related]  

  • 38. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence of anti-delta antibodies in HBsAg carriers].
    Söyletir G; Babacan F; Göral M; Can A
    Mikrobiyol Bul; 1989 Apr; 23(2):97-101. PubMed ID: 2626106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [106 cases of HBsAg carriers and factors influencing the prognosis: a follow-up study of 7-12 years].
    Hong DQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Aug; 6(4):223-6. PubMed ID: 4092225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.